Gabriela Alexe
Authors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United KingdomAuthors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United KingdomAuthors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United KingdomAuthors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom
Kimberly Stegmaier
Authors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United KingdomAuthors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United KingdomAuthors' Affiliations: Departments of Pediatric Oncology and Medical Oncology, Dana-Farber Cancer Institute; Boston Children's Hospital; Department of Medicine, Harvard Medical School; Bioinformatics Graduate Program, Boston University, Boston; The Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge; Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts; Department of Pediatrics, Helen Diller Family Comprehensive Cancer Center; Departments of Neurology and Neurosurgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, California; and Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom
